Structures by: Ouyang P.
Total: 25
C43H44N4NiO6S
C43H44N4NiO6S
Organic & biomolecular chemistry (2011) 9, 20 7144-7150
a=9.859(2)Å b=17.767(4)Å c=12.361(3)Å
α=90.00° β=91.25(3)° γ=90.00°
C29H37NO7
C29H37NO7
RSC Adv. (2014) 4, 26 13533
a=10.115(2)Å b=8.7910(18)Å c=15.671(3)Å
α=90.00° β=103.74(3)° γ=90.00°
C8H34B10N6NiO40
C8H34B10N6NiO40
Dalton transactions (Cambridge, England : 2003) (2010) 39, 25 5772-5773
a=14.4598(17)Å b=11.7213(17)Å c=8.5302(14)Å
α=90.00° β=90.875(10)° γ=90.00°
1-(3-Nitrophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-one
C11H10N4O3
Acta Crystallographica Section E (2005) 61, 7 o1997-o1998
a=26.334(8)Å b=4.5962(13)Å c=9.570(3)Å
α=90.00° β=90.00° γ=90.00°
2-(1H-1,2,3-Benzotriazol-1-ylmethyl)-1-(4-chlorobenzoyl)ethyl 2,4-dichlorobenzoate
C22H14Cl3N3O3
Acta Crystallographica Section E (2006) 62, 7 o2793-o2794
a=11.941(3)Å b=25.588(6)Å c=13.780(3)Å
α=90.00° β=100.508(4)° γ=90.00°
1-(4-Chlorophenyl)3-(4-trifluoromethylbenzoylhydrazino)prop-2-en-1-one
C17H12ClF3N2O2
Acta Crystallographica Section E (2004) 60, 12 o2468-o2470
a=7.6851(14)Å b=8.8523(16)Å c=25.104(4)Å
α=86.897(3)° β=88.293(3)° γ=72.739(3)°
6-Methoxycarbonyl-2-methyl-1H-benzimidazol-3-ium nitrate hemihydrate
C10H11N2O2,NO3,0.5H2O
Acta Crystallographica Section E (2004) 60, 12 o2441-o2443
a=7.9107(6)Å b=21.5276(17)Å c=14.2691(11)Å
α=90.00° β=94.573(2)° γ=90.00°
2-(1H-Benzotriazol-1-yl)-1-(2,5-dichlorophenyl)-2-(1H-1,2,4-triazol-1- yl)ethanone
C16H10Cl2N6O
Acta Crystallographica Section E (2006) 62, 1 o356-o357
a=7.6217(6)Å b=8.6107(8)Å c=25.5989(19)Å
α=90.00° β=107.322(2)° γ=90.00°
2-(2-Fluoro-5-methylphenyl)-2-oxo-1-(1H-1,2,4-triazol-1-yl)ethyl morpholine-4-carbodithioate
C16H17FN4O2S2
Acta Crystallographica Section E (2006) 62, 1 o358-o359
a=6.7311(13)Å b=7.7910(15)Å c=18.107(4)Å
α=98.200(3)° β=92.649(4)° γ=109.900(3)°
1-{[2-(Bromomethyl)-2-(4-chlorophenyl)-1,3-dioxolan-4-yl]methyl}- 1H-1,2,4-triazole
C13H13BrClN3O2
Acta Crystallographica Section E (2006) 62, 6 o2183-o2184
a=17.0510(12)Å b=7.6708(6)Å c=11.2732(8)Å
α=90.00° β=101.4190(10)° γ=90.00°
2-(1H-1,2,3-Benzotriazol-1-ylmethyl)-1-(4-chlorobenzoyl)ethyl nicotinate
C21H15ClN4O3
Acta Crystallographica Section E (2006) 62, 6 o2302-o2303
a=18.820(2)Å b=5.3367(6)Å c=19.027(2)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 3-methyl-1-(3-methylbenzoyl)-5-(methylsulfanyl)-1H-pyrazole-4-carboxylate
C16H18N2O3S
Acta Crystallographica Section E (2004) 60, 6 o1026-o1028
a=7.677(3)Å b=9.228(3)Å c=12.271(4)Å
α=81.745(5)° β=73.352(5)° γ=73.583(5)°
1-(4-Nitrophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-one
C11H10N4O3
Acta Crystallographica Section E (2005) 61, 10 o3394-o3395
a=9.8529(7)Å b=5.4011(4)Å c=21.9132(14)Å
α=90.00° β=103.233(3)° γ=90.00°
2-(1H-Benzotriazol-1-yl))-1-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1- yl)ethanone
C16H10Cl2N6O
Acta Crystallographica Section E (2005) 61, 10 o3232-o3233
a=21.950(3)Å b=9.9632(15)Å c=15.538(2)Å
α=90.00° β=106.028(2)° γ=90.00°
Μ-Adipato-κ^4^O,O:O'',O'''-bis[aqua(2,9-dimethyl-1,10-phenanthroline- κ^2^N,N)nitratocadmium(II)] dihydrate
C34H36Cd2N6O12,2H2O
Acta Crystallographica Section E (2005) 61, 10 m2058-m2059
a=24.438(2)Å b=11.2315(10)Å c=13.8799(12)Å
α=90.00° β=96.9690(10)° γ=90.00°
Diaqua bis(6-nitro-3H-benzimidazol) copper(II) dinitrate
[Cu(C7H5N3O2)2(H2O)2]2,2NO31
Acta Crystallographica Section E (2005) 61, 2 m235-m236
a=7.2372(8)Å b=8.1279(9)Å c=9.1779(10)Å
α=69.491(2)° β=78.012(2)° γ=84.999(2)°
1-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-1-one hemihydrate
C11H11N3O,0.5H2O
Acta Crystallographica Section E (2005) 61, 6 o1641-o1642
a=25.429(9)Å b=8.209(5)Å c=10.502(6)Å
α=90.00° β=95.595(9)° γ=90.00°
3-(1H-1,2,3-Benzotriazol-1-yl)-1-(4-methoxyphenyl)propan-1-one
C16H15N3O2
Acta Crystallographica Section E (2005) 61, 6 o1793-o1794
a=8.6112(9)Å b=21.669(2)Å c=8.1152(8)Å
α=90.00° β=106.820(2)° γ=90.00°
3-(1H-Imidazol-1-yl)1-phenylpropan-1-one
C12H12N2O
Acta Crystallographica Section E (2005) 61, 11 o3632-o3633
a=12.5860(14)Å b=10.3777(12)Å c=8.0771(9)Å
α=90.00° β=102.095(2)° γ=90.00°
N,N'-Bis(4-pyridylformyl)piperazine
C16H16N4O2
Acta Crystallographica Section E (2005) 61, 7 o1981-o1982
a=9.206(3)Å b=8.282(3)Å c=11.347(3)Å
α=90.00° β=123.255(17)° γ=90.00°
3-(1H-Imidazol-1-yl)-1-(4-methoxyphenyl)propan-1-one
C13H14N2O2
Acta Crystallographica Section E (2005) 61, 8 o2585-o2586
a=21.349(6)Å b=5.2657(14)Å c=21.303(6)Å
α=90.00° β=97.600(4)° γ=90.00°
1-(4-Chlorophenyl)-3-(1H-imidazol-1-yl)propan-1-one
C12H11ClN2O
Acta Crystallographica Section E (2005) 61, 8 o2659-o2660
a=10.4902(9)Å b=8.1611(7)Å c=13.8691(12)Å
α=90.00° β=107.2520(10)° γ=90.00°
1,6-Bis(pyridine-4-carboxamido)hexane
C18H22N4O2
Acta Crystallographica Section E (2005) 61, 4 o1103-o1104
a=5.0940(9)Å b=5.2911(10)Å c=30.759(6)Å
α=90.00° β=91.067(3)° γ=90.00°
3-(Benzotriazol-1-yl)-1-(p-tolyl)-2-(1H-1,2,4-triazol-2-yl)propan-1-one
C18H16N6O
Acta Crystallographica Section E (2006) 62, 9 o3670-o3671
a=30.972(3)Å b=8.1625(8)Å c=14.6599(14)Å
α=90.00° β=116.9270(10)° γ=90.00°
2-(1H-1,2,3-Benzotriazol-1-ylmethyl)-1-(4-methylbenzoyl)ethyl benzoate
C23H19N3O3
Acta Crystallographica Section E (2006) 62, 10 o4410-o4411
a=9.5987(9)Å b=10.2272(9)Å c=11.4321(10)Å
α=116.4820(10)° β=96.9280(10)° γ=97.4440(10)°